RYOAX Holdings — Biotechnology Fund
Data updated: 2026-08-28
RYOAX holds 74 securities. The top 10 make up 36.2% of net assets, led by Abbvie Inc.com (8.17%) and Amgen Inc.com (5.05%). Health Care (98.8%) and Funds & ETFs (0.6%) are the largest sectors, and 85.8% of the portfolio is in United States. No debt holdings are reported.
Holdings cover 100.79% of net asset value (100.00% of total assets). As of June 30, 2026 · N-PORT.
RYOAX Portfolio Holdings
74 holdings of Biotechnology Fund by percentage of net assets, from the fund's SEC N-PORT filing as of June 30, 2026.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Abbvie Inc.com | ABBV | Health Care | 8.17% | $11.18M |
| Amgen Inc.com | AMGN | Health Care | 5.05% | $6.90M |
| Gilead Sciences Inc.com | GILD | Health Care | 4.49% | $6.15M |
| Vertex Pharmaceuticals Inc.com | VRTX | Health Care | 4.32% | $5.91M |
| Regeneron Pharmaceuticals Inc.com | REGN | Health Care | 2.93% | $4.01M |
| Revolution Medicines Inc.com | RVMD | Health Care | 2.48% | $3.39M |
| Alnylam Pharmaceuticals Inc.com | ALNY | Health Care | 2.36% | $3.23M |
| Beone Medicines Ltd. Sponsored ADS | ONC | Health Care | 2.17% | $2.97M |
| Moderna Inc.com | MRNA | Health Care | 2.15% | $2.94M |
| Biogen Inc.com | BIIB | Health Care | 2.13% | $2.91M |
| Natera Inc.com | NTRA | Health Care | 2.12% | $2.90M |
| Royalty Pharma Plc.com Usd0.0001 Class A | RPRX | Health Care | 2.01% | $2.75M |
| Illumina Inc.com | ILMN | Health Care | 1.94% | $2.65M |
| Insmed Inc.com Par $.01 | INSM | Health Care | 1.79% | $2.45M |
| United Therapeutics Corp.com | UTHR | Health Care | 1.72% | $2.36M |
| Guardant Health Inc.com | GH | Health Care | 1.72% | $2.35M |
| Roivant Sciences Ltd. Shs | ROIV | Health Care | 1.66% | $2.27M |
| Incyte Corp.com | INCY | Health Care | 1.62% | $2.21M |
| Viatris Inc.com | VTRS | Health Care | 1.55% | $2.12M |
| Neurocrine Biosciences Inc.com | NBIX | Health Care | 1.52% | $2.08M |
| Argenx SE Sponsored ADR | ARGX | Health Care | 1.48% | $2.02M |
| Jazz Pharmaceuticals Plc.com Usd0.0001 | JAZZ | Health Care | 1.42% | $1.94M |
| Bridgebio Pharma Inc.com | BBIO | Health Care | 1.38% | $1.89M |
| Ionis Pharmaceuticals Inc.com | IONS | Health Care | 1.35% | $1.85M |
| Cytokinetics Inc.com New | CYTK | Health Care | 1.35% | $1.85M |
| Exelixis Inc.com | EXEL | Health Care | 1.33% | $1.82M |
| Alkermes Plc.com Usd0.01 | ALKS | Health Care | 1.31% | $1.80M |
| Arrowhead Pharmaceuticals Inc.com | ARWR | Health Care | 1.25% | $1.71M |
| Biomarin Pharmaceutical Inc.com | BMRN | Health Care | 1.24% | $1.70M |
| Astrazeneca PLC Ord Usd0.25 | AZN | Health Care | 1.23% | $1.68M |
| Halozyme Therapeutics Inc.com | HALO | Health Care | 1.17% | $1.60M |
| Biontech SE Sponsored ADS | BNTX | Health Care | 1.16% | $1.59M |
| Crispr Therapeutics Ag.com Chf0.03 | CRSP | Health Care | 1.16% | $1.58M |
| Vaxcyte Inc.com | PCVX | Health Care | 1.16% | $1.58M |
| Tg Therapeutics Inc.com | TGTX | Health Care | 1.08% | $1.48M |
| Medpace Holdings Inc.com | MEDP | Health Care | 1.03% | $1.41M |
| Apogee Therapeutics Inc.com | APGE | Health Care | 1.02% | $1.40M |
| Cogent Biosciences Inc.com | COGT | Health Care | 1.00% | $1.37M |
| Twist Bioscience Corp.com | TWST | Health Care | 0.98% | $1.35M |
| Ptc Therapeutics Inc.com | PTCT | Health Care | 0.98% | $1.35M |
| Scholar Rock Holding Corp.com | SRRK | Health Care | 0.98% | $1.35M |
| Nuvalent Inc.com | NUVL | Health Care | 0.98% | $1.35M |
| Axsome Therapeutics Inc.com | AXSM | Health Care | 0.96% | $1.31M |
| Cg Oncology Inc.com | CGON | Health Care | 0.96% | $1.31M |
| Krystal Biotech Inc.com | KRYS | Health Care | 0.93% | $1.27M |
| Viking Therapeutics Inc.com | VKTX | Health Care | 0.90% | $1.23M |
| Travere Therapeutics Inc.com | TVTX | Health Care | 0.90% | $1.23M |
| Protagonist Therapeutics Inc.com | PTGX | Health Care | 0.89% | $1.21M |
| Ascendis Pharma A/s Ord Shs | ASND | Health Care | 0.89% | $1.21M |
| Veracyte Inc.com | VCYT | Health Care | 0.88% | $1.20M |
| Liquidia Corp.com New | LQDA | Health Care | 0.86% | $1.18M |
| Kymera Therapeutics Inc.com | KYMR | Health Care | 0.83% | $1.14M |
| Madrigal Pharmaceuticals Inc.com | MDGL | Health Care | 0.79% | $1.09M |
| Ultragenyx Pharmaceutical Inc.com | RARE | Health Care | 0.77% | $1.05M |
| Beam Therapeutics Inc.com | BEAM | Health Care | 0.74% | $1.02M |
| Immunitybio Inc.com | IBRX | Health Care | 0.74% | $1.01M |
| Mirum Pharmaceuticals Inc.com | MIRM | Health Care | 0.74% | $1.01M |
| Praxis Precision Medicines Inc.com New | PRAX | Health Care | 0.72% | $988.63K |
| Rhythm Pharmaceuticals Inc.com | RYTM | Health Care | 0.71% | $978.06K |
| Acadia Pharmaceuticals Inc.com | ACAD | Health Care | 0.71% | $975.21K |
| Intellia Therapeutics Inc.com | NTLA | Health Care | 0.65% | $887.69K |
| Arcutis Biotherapeutics Inc.com | ARQT | Health Care | 0.63% | $859.99K |
| Dreyfus Treasury Obligations Cash Management | DTRXX | Funds & ETFs | 0.59% | $810.75K |
| Recursion Pharmaceuticals, Inc. Cl A | RXRX | Health Care | 0.55% | $748.63K |
| Sarepta Therapeutics Inc.com | SRPT | Health Care | 0.54% | $742.65K |
| Summit Therapeutics Inc.com | SMMT | Health Care | 0.53% | $727.28K |
| Legend Biotech Corp. Sponsored ADS | LEGN | Health Care | 0.50% | $688.59K |
| Adma Biologics Inc.com | ADMA | Health Care | 0.50% | $688.21K |
| Celcuity Inc.com | CELC | Health Care | 0.45% | $619.14K |
| Grail Inc.com | GRAL | Health Care | 0.38% | $521.10K |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated Tri Party | — | Unknown | 0.30% | $407.59K |
| J.p. Morgan Securities LLC Tri Party | — | Unknown | 0.30% | $407.61K |
| Akero Therapeutics Inc | AKRO | Health Care | 0.00% | $2 |
| Sanofi SA - Cvr | — | Health Care | 0.00% | $1 |
RYOAX Sector Allocation
Biotechnology Fund holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 98.8% | 71 |
| Funds & ETFs | 0.6% | 1 |
| Unknown | 0.6% | 2 |
RYOAX Country Allocation
Where Biotechnology Fund's holdings are domiciled, by percentage of net assets (largest 9).
| Country | % of net assets |
|---|---|
| United States | 85.8% |
| Switzerland | 3.3% |
| United Kingdom | 3.2% |
| Ireland | 2.7% |
| Bermuda | 1.7% |
| Netherlands | 1.5% |
| Germany | 1.2% |
| Denmark | 0.9% |
| Cayman Islands | 0.5% |
RYOAX Portfolio Allocation
Asset-class allocation of Biotechnology Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.6% |
| Cash & Equivalents | 1.2% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.